Blockade of Tumor-induced Immunosuppression By NGM707

Status

Published

on 30 Dec 2020

Year of Creation

2020

NGM Biopharmaceuticals, Inc

Registration Number

VA0002239348

on 30 Dec 2020

The U.S. Copyright record (Registration Number: VA0002239348) dated 30 Dec 2020, pertains to an electronic file (eService) titled "Blockade of Tumor-induced Immunosuppression By NGM707" created in 2020. The copyright holder is NGM Biopharmaceuticals, Inc, known for their creative contributions in visual material registration. For any inquiries concerning this copyrighted material, kindly reach out to NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc

Application Details

Registration Number

VA0002239348

Registration Date

12/30/2020

Year of Creation

2020

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Orrbitt Creative Group, LLC

Physical Description

Electronic file (eService)

First Publication Nation

United States

Corporate Authors

LLC Orrbitt Creative Group

Inc NGM Biopharmaceuticals

Notes

Rights Note: Ilene B. Tannen, Jones Day - Attn: Ilene Tannen, 250 Vesey Street, New York, NY, 10281, United States, (917) 833-5621, (212) 326-3411, ibtannen@jonesday.com

Statements

Application Title Statement: Blockade of Tumor-induced Immunosuppression By NGM707

Author Statement: Orrbitt Creative Group, LLC (author of anonymous contribution) employer for hire Domicile: United States Authorship: 2-D artwork, Scientific Drawing

Notes

Rights Note: Ilene B. Tannen, Jones Day - Attn: Ilene Tannen, 250 Vesey Street, New York, NY, 10281, United States, (917) 833-5621, (212) 326-3411, ibtannen@jonesday.com

Statements

Application Title Statement: Blockade of Tumor-induced Immunosuppression By NGM707

Author Statement: Orrbitt Creative Group, LLC (author of anonymous contribution) employer for hire Domicile: United States Authorship: 2-D artwork, Scientific Drawing

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.